| Name | Title | Contact Details |
|---|
The Pennsylvania Medical Society Alliance is an organization of physicians' spouses dedicated to the health of America.
"Eleven uses its proprietary technology platform to create first-of-a-kind protein therapeutics to address unmet needs for ophthalmic diseases. Proteins are able to modulate inflammatory cytokines, key targets in ocular disease that have been difficult to access with conventional therapeutic approaches. A significant untapped opportunity exists for protein therapeutics to address ophthalmic diseases, and Eleven is applying its advanced protein technology and expertise to develop innovative medicines for patients suffering from ocular diseases. Eleven`s team of industry veterans has deep experience in understanding protein science and biologic drug development, designing and conducting clinical trials and, most importantly, applying specific expertise in ophthalmic disease to create novel ocular therapeutics to treat unmet medical needs. Eleven has developed a proprietary pipeline of ophthalmic drug candidates derived from the company`s innovative AMP-Rx protein engineering technology. The company`s initial product candidates are focused on targeting inflammatory cytokines and key targets of ocular disease by blocking the cytokines and modulating the biological processes that drive ocular disease. Current pipeline opportunities include ocular surface diseases such as dry eye disease (DED) and allergic conjunctivitis (AC), and back of the eye diseases such as diabetic macular edema (DME) and uveitis. In addition, Eleven’s proprietary technology has been utilized to prolong the intravitreal half-life of our pipeline products. Beyond its internal drug development programs, Eleven works with collaborators, such as ThromboGenics, to apply its innovative protein therapeutic design capabilities to engineer and develop biotherapeutic products for additional therapeutic targets. EBI-005, Eleven`s lead product candidate, is a novel interleukin-1 (IL-1) receptor antagonist in Phase 3 clinical development as one of the first topically administered proteins for the treatment of DED and AC, two inflammatory diseases at the surface of the eye."
Dinatec is a Gainesville, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
ANX Home Healthcare provides physician-ordered skilled nursing and health care services to homebound patients recovering from illness or injury. We have worked with physicians and families in developing custom home care solutions for patients requiring specialists in: • Wound care • Diabetes management • Cardiac rehabilitation • Physical therapy • Occupational therapy • Speech therapy • Nutritional assessments • Dietary counseling Our services are provided by a highly skilled interdisciplinary team of experts with over 75 years of combined experience in the health care industry. We pride ourselves in our ability to quickly respond to physician and clinician requests for patient home care. Best of all, you can count on us to provide service 24/7. With a team of full-time clinicians, we are able to initiate start of care within 24 hours. Established by Thomas Allandale Rocas III (RN, BSN, Certified Wound Care Specialist) and Lisa Mangubat (RN, BSN) in August 2007 with a vision of client-focused quality care and service for home-bound patients, ANX Home Healthcare is now in our ninth year of practice in the San Francisco Bay Area. We remain committed to providing competent and reliable care utilizing cutting-edge technology.
O. I. Medical is a Austin, TX-based company in the Healthcare, Pharmaceuticals, & Biotech sector.